Clinical Trial Update: A Polypill for Secondary Prevention of Ischemic Heart Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for a polypill intended for secondary prevention after ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Acute Myocardial Infarction, ST Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN